Hydrogen peroxide vapour (HPV) inactivation of adenovirus

Letters in Applied Microbiology

Volumn 52, Issue 5, 2011, Pages 555-558

  Berrie, E ^a   Andrews, L ^a   Yezli, S ^b   Otter, J A ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Bioquell UK Ltd   (United Kingdom)

Author keywords

Adenovirus; Decontamination; Hydrogen peroxide vapour

Indexed keywords

CONTAMINATION; DECONTAMINATION; HYDROGEN PEROXIDE; OXIDATION;

ADENOVIRUS; CROSS CONTAMINATION; HYDROGEN PEROXIDE VAPORS; LIFE-SCIENCES; PERSONNEL EXPOSURE; PHARMACEUTICAL MANUFACTURING PROCESS; RECOMBINANT ADENOVIRUS; SCIENCE LABORATORIES; SPORICIDAL; STRINGENTS;

VIRUSES;

HYDROGEN PEROXIDE;

DRUG; FUNGICIDE; HYDROGEN PEROXIDE; LABORATORY METHOD; LIFE SCIENCE; MANUFACTURING; RECOMBINATION; RISK ASSESSMENT; SURVIVAL; VIRUS;

ADENOVIRUS; ARTICLE; DISINFECTION; VAPOR; VIRUS INACTIVATION; VIRUS RECOMBINANT; VIRUS SURVIVAL;

ADENOVIRIDAE; HUMAN PAPILLOMAVIRUS;

EID: 79953747551     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2011.03033.x     Document Type: Article

References (19)

1. Dettenkofer, M. and Block, C. (2005) Hospital disinfection: efficacy and safety issues. Curr Opin Infect Dis 18, 320-325.
2. French, G.L., Otter, J.A., Shannon, K.P., Adams, N.M., Watling, D. and Parks, M.J. (2004) Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect 57, 31-37.
3. Goncalves, M.A. and De Vries, A.A. (2006) Adenovirus: from foe to friend. Rev Med Virol 16, 167-186.
4. Hall, L., Otter, J.A., Chewins, J. and Wengenack, N.L. (2007) Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. J Clin Microbiol 45, 810-815.
5. Hall, L., Otter, J.A., Chewins, J. and Wengenack, N.L. (2008) Deactivation of the dimorphic fungi Histoplasma capsulatum, Blastomyces dermatitidis and Coccidioides immitis using hydrogen peroxide vapor. Med Mycol 46, 189-191.
6. Heckert, R.A., Best, M., Jordan, L.T., Dulac, G.C., Eddington, D.L. and Sterritt, W.G. (1997) Efficacy of vaporized hydrogen peroxide against exotic animal viruses. Appl Environ Microbiol 63, 3916-3918.
7. Hitt, M.M., Addison, C.L. and Graham, F.L. (1997) Human adenovirus vectors for gene transfer into mammalian cells. Adv Pharmacol 40, 137-206.
8. Johnston, M.D., Lawson, S. and Otter, J.A. (2005) Evaluation of hydrogen peroxide vapour as a method for the decontamination of surfaces contaminated with Clostridium botulinum spores. J Microbiol Methods 60, 403-411.
9. Karber, G. (1931) Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Arch Exp Path Pharmak 162, 480.
10. Kojaoghlanian, T., Flomenberg, P. and Horwitz, M.S. (2003) The impact of adenovirus infection on the immunocompromised host. Rev Med Virol 13, 155-171.
11. Leen, A.M. and Rooney, C.M. (2005) Adenovirus as an emerging pathogen in immunocompromised patients. Br J Haematol 128, 135-144.
12. Losert, A., Mauritz, I., Erlach, N., Herbacek, I., Schulte-Hermann, R., Holzmann, K. and Grusch, M. (2006) Monitoring viral decontamination procedures with green fluorescent protein-expressing adenovirus. Anal Biochem 355, 310-312.
13. Mahl, M.C. and Sadler, C. (1975) Virus survival on inanimate surfaces. Can J Microbiol 21, 819-823.
14. Pottage, T., Richardson, C., Parks, S., Walker, J.T. and Bennett, A.M. (2010) Evaluation of hydrogen peroxide gaseous disinfection systems to decontaminate viruses. J Hosp Infect 74, 55-61.
15. Rutala, W.A., Peacock, J.E., Gergen, M.F., Sobsey, M.D. and Weber, D.J. (2006) Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities. Antimicrob Agents Chemother 50, 1419-1424.
16. Rutala, W.A., Weber, D.J. and the Healthcare Infection Control Practices Advisory Committee (HICPAC). (2008). The CDC 2008 guideline for disinfection and sterilization in healthcare facilities. Available at: (accessed 8 July 2010).
17. Sattar, S.A., Springthorpe, V.S., Karim, Y. and Loro, P. (1989) Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses. Epidemiol Infect 102, 493-505.
18. Sofer, G. (1995) Validation of biotechnology products and processes. Curr Opin Biotechnol 6, 230-234.
19. Sofer, G. (2003) Virus inactivation in the 1990s and into the 21st century. Part 5: disinfection. Biopharmaceuticals 16, 44-48.